Share on StockTwits

Healthways (NASDAQ:HWAY) has received a consensus rating of “Hold” from the eleven ratings firms that are presently covering the company, Stock Ratings News reports. Two research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $16.83.

A number of research firms have recently commented on HWAY. Analysts at Zacks upgraded shares of Healthways from an “underperform” rating to a “neutral” rating in a research note on Tuesday, May 27th. They now have a $18.00 price target on the stock. Separately, analysts at Noble Financial upgraded shares of Healthways from a “hold” rating to a “buy” rating in a research note on Friday, April 25th. They now have a $21.00 price target on the stock, up previously from $12.00. Finally, analysts at Stifel Nicolaus reiterated a “buy” rating on shares of Healthways in a research note on Friday, April 25th. They now have a $21.00 price target on the stock, up previously from $17.00.

Shares of Healthways (NASDAQ:HWAY) opened at 16.85 on Friday. Healthways has a 52 week low of $9.59 and a 52 week high of $22.20. The stock has a 50-day moving average of $17.49 and a 200-day moving average of $15.75. The company’s market cap is $594.3 million.

Healthways (NASDAQ:HWAY) last released its earnings data on Thursday, April 24th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.05. The company had revenue of $176.80 million for the quarter, compared to the consensus estimate of $177.13 million. During the same quarter in the previous year, the company posted ($0.12) earnings per share. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. On average, analysts predict that Healthways will post $0.20 earnings per share for the current fiscal year.

Healthways, Inc provides solutions to help people improve physical, emotional and social well-being. The Company provides specific and personalized interventions for each individual in a population, irrespective of health status, age or payor.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.